<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01051804</url>
  </required_header>
  <id_info>
    <org_study_id>SMA-09-33</org_study_id>
    <nct_id>NCT01051804</nct_id>
  </id_info>
  <brief_title>Evaluation of the Repeated Usage of Systane Ultra Eyedrop</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparison of two contact lens solutions.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2009</start_date>
  <primary_completion_date type="Actual">July 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement in objective vision</measure>
    <time_frame>4 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Measurement of tear film evaporation</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">57</enrollment>
  <condition>Dry Eye</condition>
  <arm_group>
    <arm_group_label>Systane Ultra</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Systane Ultra Lubricant Eye Drops</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Optive</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Optive Lubricant Eye Drops</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Systane Ultra</intervention_name>
    <description>Systane Ultra 1 to 2 drops per eye at least 4 times daily for 4 weeks</description>
    <arm_group_label>Systane Ultra</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Optive lubricant Eye Drops</intervention_name>
    <description>Optive Lubricant Eye Drops 1 to 2 drops per eye at least 4 times daily for 4 weeks</description>
    <arm_group_label>Optive</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 years or more.

          -  Non contact lens wearer.

          -  Symptomatology as defined below for the Ocular Surface Disease Index (OSDI)
             questionnaire:

               -  Score â‰¥13 for OSDI Questionnaire total score; AND

               -  Scores of at least 2 for 2 out of the 6 vision related questions of the OSDI
                  questionnaire

          -  Best visual acuity of 6/9 or better in each eye.

          -  Willingness to adhere to the instructions set in the clinical protocol.

          -  Signature of the subject informed consent form.

        Exclusion Criteria:

          -  Use of systemic medication which might produce dry eye side effects.

          -  Systemic disease which might produce dry eye side effects.

          -  Active ocular infection.

          -  Use of ocular medication.

          -  Significant ocular anomaly.

          -  Previous ocular surgery

          -  Previous use of Restasis

          -  Any medical condition that might be prejudicial to the study.

          -  The subject, based on their knowledge, must NOT be pregnant or lactating at the time
             of enrolment.

          -  The subject, based on his/her knowledge, must NOT have an infectious disease (e.g.
             hepatitis, tuberculosis) or an immunosuppressive disease (e.g. Human Immunodeficiency
             Virus).

          -  The subject, based on their knowledge, must NOT have diabetes.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <verification_date>January 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 18, 2010</study_first_submitted>
  <study_first_submitted_qc>January 19, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 20, 2010</study_first_posted>
  <last_update_submitted>January 31, 2012</last_update_submitted>
  <last_update_submitted_qc>January 31, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 2, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Dry eye</keyword>
  <keyword>Visual Performance</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ophthalmic Solutions</mesh_term>
    <mesh_term>Tetrahydrozoline</mesh_term>
    <mesh_term>Lubricant Eye Drops</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

